Therapeutic Challenges in Management of Severe Acidosis and Profound Hypokalemia in Pediatric Diabetic Ketoacidosis

Profound hypokalemia in the presence of diabetic ketoacidosis (DKA) is life-threatening condition predisposing patients to cardiac arrhythmias and potentially death. Rarely do patients present with profound hypokalemia (serum K + level <2.5 mEq/L). Pediatric patients who present to the hospital w...

Full description

Bibliographic Details
Main Authors: Ayush Gupta MD, Nidal El-Wiher MD
Format: Article
Language:English
Published: SAGE Publishing 2019-04-01
Series:Global Pediatric Health
Online Access:https://doi.org/10.1177/2333794X19840364
id doaj-7036122b505a4c1fbeaebfdc9569131c
record_format Article
spelling doaj-7036122b505a4c1fbeaebfdc9569131c2020-11-25T02:52:41ZengSAGE PublishingGlobal Pediatric Health2333-794X2019-04-01610.1177/2333794X19840364Therapeutic Challenges in Management of Severe Acidosis and Profound Hypokalemia in Pediatric Diabetic KetoacidosisAyush Gupta MD0Nidal El-Wiher MD1Beaumont Health System, Royal Oak, MI, USABeaumont Health System, Royal Oak, MI, USAProfound hypokalemia in the presence of diabetic ketoacidosis (DKA) is life-threatening condition predisposing patients to cardiac arrhythmias and potentially death. Rarely do patients present with profound hypokalemia (serum K + level <2.5 mEq/L). Pediatric patients who present to the hospital with new-onset DKA with no past medical history and have profound severe hypokalemia and acidosis can be very difficult to manage. Given insulin to these patients immediately can lead to further decrease in extracellular potassium level and lead to cardiac dysrhythmias and death. We present the case of a 14-year-old female with new-onset DKA with pH of 6.66, and potassium of 1.6 mEq/L. We started her on careful potassium replacement before starting her on insulin. She had a great prognosis without any complications. Our case presents the lowest level of pH ever reported in a survived pediatric DKA patient. We emphasize the importance of careful management of hypokalemia in patients with severe depletion. Potassium therapy with careful fluid management must be initiated prior to insulin therapy to prevent cardiac completions from hypokalemia.https://doi.org/10.1177/2333794X19840364
collection DOAJ
language English
format Article
sources DOAJ
author Ayush Gupta MD
Nidal El-Wiher MD
spellingShingle Ayush Gupta MD
Nidal El-Wiher MD
Therapeutic Challenges in Management of Severe Acidosis and Profound Hypokalemia in Pediatric Diabetic Ketoacidosis
Global Pediatric Health
author_facet Ayush Gupta MD
Nidal El-Wiher MD
author_sort Ayush Gupta MD
title Therapeutic Challenges in Management of Severe Acidosis and Profound Hypokalemia in Pediatric Diabetic Ketoacidosis
title_short Therapeutic Challenges in Management of Severe Acidosis and Profound Hypokalemia in Pediatric Diabetic Ketoacidosis
title_full Therapeutic Challenges in Management of Severe Acidosis and Profound Hypokalemia in Pediatric Diabetic Ketoacidosis
title_fullStr Therapeutic Challenges in Management of Severe Acidosis and Profound Hypokalemia in Pediatric Diabetic Ketoacidosis
title_full_unstemmed Therapeutic Challenges in Management of Severe Acidosis and Profound Hypokalemia in Pediatric Diabetic Ketoacidosis
title_sort therapeutic challenges in management of severe acidosis and profound hypokalemia in pediatric diabetic ketoacidosis
publisher SAGE Publishing
series Global Pediatric Health
issn 2333-794X
publishDate 2019-04-01
description Profound hypokalemia in the presence of diabetic ketoacidosis (DKA) is life-threatening condition predisposing patients to cardiac arrhythmias and potentially death. Rarely do patients present with profound hypokalemia (serum K + level <2.5 mEq/L). Pediatric patients who present to the hospital with new-onset DKA with no past medical history and have profound severe hypokalemia and acidosis can be very difficult to manage. Given insulin to these patients immediately can lead to further decrease in extracellular potassium level and lead to cardiac dysrhythmias and death. We present the case of a 14-year-old female with new-onset DKA with pH of 6.66, and potassium of 1.6 mEq/L. We started her on careful potassium replacement before starting her on insulin. She had a great prognosis without any complications. Our case presents the lowest level of pH ever reported in a survived pediatric DKA patient. We emphasize the importance of careful management of hypokalemia in patients with severe depletion. Potassium therapy with careful fluid management must be initiated prior to insulin therapy to prevent cardiac completions from hypokalemia.
url https://doi.org/10.1177/2333794X19840364
work_keys_str_mv AT ayushguptamd therapeuticchallengesinmanagementofsevereacidosisandprofoundhypokalemiainpediatricdiabeticketoacidosis
AT nidalelwihermd therapeuticchallengesinmanagementofsevereacidosisandprofoundhypokalemiainpediatricdiabeticketoacidosis
_version_ 1724728329726066688